A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000704:Analysis of Variance; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010868:Pimozide / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D010868:Pimozide; D014268:Trifluoperazine